Energetics of the HIV gp120-CD4 binding reaction
- PMID: 10922058
- PMCID: PMC16815
- DOI: 10.1073/pnas.97.16.9026
Energetics of the HIV gp120-CD4 binding reaction
Abstract
HIV infection is initiated by the selective interaction between the cellular receptor CD4 and gp120, the external envelope glycoprotein of the virus. We used analytical ultracentrifugation, titration calorimetry, and surface plasmon resonance biosensor analysis to characterize the assembly state, thermodynamics, and kinetics of the CD4-gp120 interaction. The binding thermodynamics were of unexpected magnitude; changes in enthalpy, entropy, and heat capacity greatly exceeded those described for typical protein-protein interactions. These unusual thermodynamic properties were observed with both intact gp120 and a deglycosylated and truncated form of gp120 protein that lacked hypervariable loops V1, V2, and V3 and segments of its N and C termini. Together with previous crystallographic studies, the large changes in heat capacity and entropy reveal that extensive structural rearrangements occur within the core of gp120 upon CD4 binding. CD spectral studies and slow kinetics of binding support this conclusion. These results indicate considerable conformational flexibility within gp120, which may relate to viral mechanisms for triggering infection and disguising conserved receptor-binding sites from the immune system.
Figures






Similar articles
-
Thermodynamics of binding of a low-molecular-weight CD4 mimetic to HIV-1 gp120.Biochemistry. 2006 Sep 12;45(36):10973-80. doi: 10.1021/bi061193r. Biochemistry. 2006. PMID: 16953583 Free PMC article.
-
Molecular dynamics simulations reveal distinct differences in conformational dynamics and thermodynamics between the unliganded and CD4-bound states of HIV-1 gp120.Phys Chem Chem Phys. 2020 Mar 11;22(10):5548-5560. doi: 10.1039/c9cp06706j. Phys Chem Chem Phys. 2020. PMID: 32119016
-
Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.J Virol. 1995 Sep;69(9):5723-33. doi: 10.1128/JVI.69.9.5723-5733.1995. J Virol. 1995. PMID: 7543586 Free PMC article.
-
Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonist.Acc Chem Res. 2014 Apr 15;47(4):1228-37. doi: 10.1021/ar4002735. Epub 2014 Feb 6. Acc Chem Res. 2014. PMID: 24502450 Free PMC article. Review.
-
Thermodynamics-based drug design: strategies for inhibiting protein-protein interactions.Future Med Chem. 2011 Jul;3(9):1129-37. doi: 10.4155/fmc.11.81. Future Med Chem. 2011. PMID: 21806377 Free PMC article. Review.
Cited by
-
The chemokine CXCL12 and the HIV-1 envelope protein gp120 regulate spontaneous activity of Cajal-Retzius cells in opposite directions.J Physiol. 2012 Jul 1;590(13):3185-202. doi: 10.1113/jphysiol.2011.224873. Epub 2012 Apr 2. J Physiol. 2012. PMID: 22473778 Free PMC article.
-
Escape from human immunodeficiency virus type 1 (HIV-1) entry inhibitors.Viruses. 2012 Dec;4(12):3859-911. doi: 10.3390/v4123859. Viruses. 2012. PMID: 23342377 Free PMC article. Review.
-
Targeting a Neutralizing Epitope of HIV Envelope Gp120 by Immune Complex Vaccine.J AIDS Clin Res. 2012 Mar 9;S8(2):5512. doi: 10.4172/2155-6113.S8-002. J AIDS Clin Res. 2012. PMID: 22891160 Free PMC article.
-
Isolate-specific differences in the conformational dynamics and antigenicity of HIV-1 gp120.J Virol. 2013 Oct;87(19):10855-73. doi: 10.1128/JVI.01535-13. Epub 2013 Jul 31. J Virol. 2013. PMID: 23903848 Free PMC article.
-
Solid-phase proteoliposomes containing human immunodeficiency virus envelope glycoproteins.J Virol. 2002 Apr;76(7):3511-21. doi: 10.1128/jvi.76.7.3511-3521.2002. J Virol. 2002. PMID: 11884575 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials